NO20071604L - Loxapinanaloger og fremgangsmater for anvendelse derav. - Google Patents

Loxapinanaloger og fremgangsmater for anvendelse derav.

Info

Publication number
NO20071604L
NO20071604L NO20071604A NO20071604A NO20071604L NO 20071604 L NO20071604 L NO 20071604L NO 20071604 A NO20071604 A NO 20071604A NO 20071604 A NO20071604 A NO 20071604A NO 20071604 L NO20071604 L NO 20071604L
Authority
NO
Norway
Prior art keywords
methods
loxapine analogs
loxapine
analogs
relates
Prior art date
Application number
NO20071604A
Other languages
English (en)
Norwegian (no)
Inventor
Dale M Edgar
David G Hangauer
Kazumi Shiosaki
Michael Solomon
James F White
Original Assignee
Hypnion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hypnion Inc filed Critical Hypnion Inc
Publication of NO20071604L publication Critical patent/NO20071604L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20[b, f]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20071604A 2004-09-21 2007-03-27 Loxapinanaloger og fremgangsmater for anvendelse derav. NO20071604L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61184904P 2004-09-21 2004-09-21
US67319805P 2005-04-19 2005-04-19
PCT/US2005/034015 WO2006034414A2 (en) 2004-09-21 2005-09-21 Loxapine analogs and methods of use thereof

Publications (1)

Publication Number Publication Date
NO20071604L true NO20071604L (no) 2007-06-20

Family

ID=36090680

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071604A NO20071604L (no) 2004-09-21 2007-03-27 Loxapinanaloger og fremgangsmater for anvendelse derav.

Country Status (19)

Country Link
US (3) US20060063755A1 (US07981874-20110719-C00313.png)
EP (1) EP1804804B1 (US07981874-20110719-C00313.png)
JP (1) JP5049129B2 (US07981874-20110719-C00313.png)
KR (1) KR101264444B1 (US07981874-20110719-C00313.png)
AT (1) ATE542536T1 (US07981874-20110719-C00313.png)
AU (1) AU2005286713B2 (US07981874-20110719-C00313.png)
BR (1) BRPI0515518A (US07981874-20110719-C00313.png)
CA (1) CA2580250C (US07981874-20110719-C00313.png)
CY (1) CY1112590T1 (US07981874-20110719-C00313.png)
DK (1) DK1804804T3 (US07981874-20110719-C00313.png)
EA (1) EA012610B1 (US07981874-20110719-C00313.png)
ES (1) ES2378452T3 (US07981874-20110719-C00313.png)
MA (1) MA28985B1 (US07981874-20110719-C00313.png)
MX (1) MX2007003032A (US07981874-20110719-C00313.png)
NO (1) NO20071604L (US07981874-20110719-C00313.png)
NZ (1) NZ553900A (US07981874-20110719-C00313.png)
PL (1) PL1804804T3 (US07981874-20110719-C00313.png)
PT (1) PT1804804E (US07981874-20110719-C00313.png)
WO (1) WO2006034414A2 (US07981874-20110719-C00313.png)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US20050085463A1 (en) * 2003-01-23 2005-04-21 Weiner David M. Use of N-desmethylclozapine to treat human neuropsychiatric disease
US20050250767A1 (en) * 2003-01-23 2005-11-10 Weiner David M Use of N-desmethylclozapine to treat human neuropsychiatric disease
KR20050092123A (ko) * 2003-01-23 2005-09-20 아카디아 파마슈티칼스 인코포레이티드 N-데스메틸클로자핀의 인간의 신경정신성 질환의 치료용도
KR101157881B1 (ko) * 2003-12-22 2012-07-06 아카디아 파마슈티칼스 인코포레이티드 무스카린 작용제로서의 아미노 치환된 디아릴[a,d]사이클로헵텐 유사체, 및 신경정신 질환의 치료 방법
KR20070007888A (ko) * 2004-04-01 2007-01-16 아카디아 파마슈티칼스 인코포레이티드 결정질 n-데스메틸클로자핀
US7563785B2 (en) * 2004-10-29 2009-07-21 Hypnion, Inc. Quetiapine analogs and methods of use thereof
US20070105836A1 (en) * 2005-10-31 2007-05-10 Lars Pettersson Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
US7762006B2 (en) * 2006-06-14 2010-07-27 Siestamed, Technologies Medical equipment drying device
US8399452B2 (en) * 2006-10-28 2013-03-19 Methylgene Inc. Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
CN103214473A (zh) * 2007-03-15 2013-07-24 ARYx医疗有限公司 二苯并[b,f][1,4]氧杂氮杂*化合物
MX2009010000A (es) 2007-03-19 2010-03-17 Insuline Medical Ltd Dispositivo para el suministro de farmaco.
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
MX2011004817A (es) 2008-11-07 2011-07-28 Insuline Medical Ltd Dispositivo y metodo para suministrar farmacos.
WO2014116684A1 (en) * 2013-01-22 2014-07-31 Edward Roberts Non-peptidic neuropeptide y receptor modulators
CN115887456A (zh) 2015-03-26 2023-04-04 杰奎琳·M·艾弗森 抑制与宿醉相关的症状的方法和组合物
AU2020370063A1 (en) 2019-10-21 2022-06-02 Alairion, Inc. 3-(4-(llH-dibenzo[b,e][l,4]azepin-6- yl)piperazin-l-yl)- and 3- (4-(dibenzo[b,f][l,4]oxazepin/thiazepin/diazepin-11-yl)piperazin-1-yl)-propano ic acid derivatives as HI and 5- HT2A-receptor modulators for the treatment of sleep disorders

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
US3928356A (en) 1967-10-06 1975-12-23 Fujisawa Pharmaceutical Co 10-{8 4-({107 -Hydroxy alkyl)-1-piperazimyl{9 -dibenzo (h,f) oxofins and thiepins and acetyl esters thereof
NL7110453A (US07981874-20110719-C00313.png) 1970-08-06 1972-02-08 Wander Ag Dr A
US4072756A (en) * 1973-05-17 1978-02-07 Sandoz Ltd. Tricyclo piperidino ketones and soporific compositions thereof
US4642903A (en) 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
JPH04211071A (ja) * 1990-03-05 1992-08-03 Hokuriku Seiyaku Co Ltd 多環式化合物
US5578322A (en) 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5380473A (en) 1992-10-23 1995-01-10 Fuisz Technologies Ltd. Process for making shearform matrix
AU691195B2 (en) 1993-07-09 1998-05-14 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US5895664A (en) 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5622719A (en) 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5616344A (en) 1994-06-14 1997-04-01 Fuisz Technologies Ltd. Apparatus and process for strengthening low density compression dosage units and product therefrom
US5607697A (en) 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
AR008371A1 (es) 1996-05-30 2000-01-19 Novartis Ag Una sal de adicion con acido de una 10-aminoalifatil-dibenz[b,f],oxepina, su empleo; procedimiento para su elaboracion, una 10-aminoalifatil-dibenz[b,f]oxepina, una preparacion farmaceutica que contiene dicha sal o dicha oxepina y un procedimiento para el tratamiento de enfermedades neurodegenerativ
JP4563516B2 (ja) 1997-02-20 2010-10-13 マサチューセッツ インスティテュート オブ テクノロジー 迅速分散性を示す投与剤形、その使用法並びにその製造方法
US6277406B1 (en) 1997-10-08 2001-08-21 Fuisz Technologies Ltd. Easily processed tablet compositions
US7189757B2 (en) * 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
WO2003039255A1 (en) 2001-11-05 2003-05-15 Basf Aktiengesellschaft Use of substituted dibenzothiepine derivatives as insecticidal, acaricidal and nematicidal agents
BR0317528A (pt) 2002-12-20 2005-11-22 Basf Ag Uso dos compostos, métodos para o controle de insetos, aracnìdeos ou nematodos, e para a proteção de plantas em crescimento contra o ataque ou a infestação por insetos, aracnìdeos ou nematodos, compostos, e, composições
US20060063754A1 (en) 2004-09-21 2006-03-23 Edgar Dale M Methods of treating a sleep disorder

Also Published As

Publication number Publication date
EA200700702A1 (ru) 2007-10-26
US20060063928A1 (en) 2006-03-23
WO2006034414A3 (en) 2006-09-08
BRPI0515518A (pt) 2008-07-29
WO2006034414A2 (en) 2006-03-30
EP1804804B1 (en) 2012-01-25
JP2008513510A (ja) 2008-05-01
CA2580250A1 (en) 2006-03-30
US20060063755A1 (en) 2006-03-23
DK1804804T3 (da) 2012-02-20
EP1804804A2 (en) 2007-07-11
AU2005286713A1 (en) 2006-03-30
PL1804804T3 (pl) 2012-08-31
KR101264444B1 (ko) 2013-05-20
EA012610B1 (ru) 2009-10-30
US20090186872A1 (en) 2009-07-23
US7592333B2 (en) 2009-09-22
US8101596B2 (en) 2012-01-24
ATE542536T1 (de) 2012-02-15
MX2007003032A (es) 2007-05-21
PT1804804E (pt) 2012-03-30
MA28985B1 (fr) 2007-11-01
ES2378452T3 (es) 2012-04-12
JP5049129B2 (ja) 2012-10-17
CY1112590T1 (el) 2016-02-10
CA2580250C (en) 2013-05-14
NZ553900A (en) 2010-10-29
KR20070060126A (ko) 2007-06-12
AU2005286713B2 (en) 2010-10-28
EP1804804A4 (en) 2010-11-24

Similar Documents

Publication Publication Date Title
NO20071604L (no) Loxapinanaloger og fremgangsmater for anvendelse derav.
NL301145I2 (nl) Tirbanibulin
WO2006049734A3 (en) Quetiapine analogs and methods of use thereof
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
MX2007001127A (es) Moduladores de pirrolo-piridina cinasa.
ATE448234T1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
ATE461217T1 (de) Glp-1-verbindungen
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
TW200640924A (en) VEGF-R2 inhibitors and methods
ATE525372T1 (de) Pyrazinderivate als natriumkanalmodulatoren zur behandlung von schmerzen
DE602005021894D1 (de) Triazolophthalazine
SE0301653D0 (sv) Novel compounds
UY3493Q (es) Esponja
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
ECSP077270A (es) Ácidos de tiazolo - naftilo
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
ATE542796T1 (de) N-sulfonylcarboximidamidverbindungen als apoptosepromotoren
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
UY28344A1 (es) Nuevos compuestos
DK1492501T3 (da) Fremgangsmåder med anvendelse af lamellare legemer til terapeutiske formål
ATE501127T1 (de) Neue cysteinproteasehemmer und ihre therapeutische anwendung
EA200701366A1 (ru) Кислородсодержащие аннелированные фенилпиперазин- и фенилдиазепанкарбоксамиды

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

FC2A Withdrawal, rejection or dismissal of laid open patent application